Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tablo® Hemodialysis System

K-Number: K233335 · 2023-12-05

Decision Date2023-12-05
Product CodeKDI
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

Tablo® Hemodialysis System is a medical device manufactured by Outset Medical, Inc.. It received FDA 510(k) clearance on 2023-12-05 under approval number K233335. The device is classified under product code KDI. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tablo® Hemodialysis System?

Tablo® Hemodialysis System is a medical device that received FDA 510(k) clearance on 2023-12-05. It is manufactured by Outset Medical, Inc.. The 510(k) number is K233335.

When was Tablo® Hemodialysis System approved by the FDA?

Tablo® Hemodialysis System received FDA 510(k) clearance on 2023-12-05, under approval number K233335.

What company makes Tablo® Hemodialysis System?

Tablo® Hemodialysis System is manufactured by Outset Medical, Inc..

What is the FDA product code for Tablo® Hemodialysis System?

The FDA product code for Tablo® Hemodialysis System is KDI.

Related Clinical Trials

Other Devices by Outset Medical, Inc.

View all 9 devices →

Related Devices (Code: KDI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.